Report
MarketLine Department
EUR 295.79 For Business Accounts Only

Pharmaceuticals in Spain

Summary

Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Spanish pharmaceuticals market recorded revenues of $30.6 billion in 2024, representing a compound annual growth rate (CAGR) of 4.0% between 2019 and 2024.
- The central nervous system drugs segment accounted for the market's largest proportion in 2024, with total revenues of $4.3 billion, equivalent to 14.0% of the market's overall value.
- The Spanish pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.8%.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Spain
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Spain
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts by both value and volume

Reasons To Buy

- What was the size of the Spain pharmaceuticals market by value in 2024?
- What will be the size of the Spain pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Spain pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Spain's pharmaceuticals market?
Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch